[CITY, State] — March 2, 2026 — Castor, a global leader in user-centric clinical trial technology, today announced its membership in the Electronic Clinical Outcome Assessment (eCOA) Consortium at the Critical Path Institute (C-Path).
Castor’s decision to join the consortium is driven by a commitment to sharing insights gained from global research to help define the future of clinical data. This collaboration comes at a pivotal moment for Castor, as the company officially surpasses the 300 industry study mark for its eCOA solution.
Advancing the Standard for Participant-Driven Data
Castor’s eCOA platform is recognized for its ability to deliver high-quality, patient-reported data by removing the friction often found in traditional clinical research. By focusing on maximizing participant engagement, Castor ensures that researchers can capture more reliable data points across diverse therapeutic areas.
By joining the C-Path eCOA Consortium, Castor aims to leverage its experience in large-scale, high-integrity data collection to help shape the future of digital health technology standards.
“Joining the C-Path eCOA Consortium is a natural next step for Castor as we continue to scale our impact across the industry,” said Lisa Charlton, Chief Product Officer at Castor. “Passing the 300 industry study mark is a testament to the trust our partners place in our ability to capture meaningful data. We are excited to collaborate with fellow leaders to ensure eCOA and DHT-derived data are as accurate, accessible, and participant-friendly as possible, ultimately accelerating the journey from research to cure.”
About Castor
Castor is a leading provider of clinical trial technology that automates the research process. From recruitment and eConsent to eCOA, Castor’s platform is designed to help researchers capture high-quality data from any source, anywhere in the world. With a focus on maximizing participant engagement, Castor supports thousands of studies across the biotech, pharmaceutical, and medical device industries.
About Critical Path Institute (C-Path)
Critical Path Institute (C-Path) is an independent, nonprofit organization established in 2005 as a public and private partnership. C-Path’s mission is to catalyze the development of new approaches that advance medical innovation and regulatory science, accelerating the path to a healthier world.